Buprenorphine (Pain) and Gabapentin Interaction

Understanding the Buprenorphine (Pain) and Gabapentin Interaction

FDA-approved prescribing information for these two drugs flags their combination as a minor-severity interaction. Buprenorphine (Pain) belongs to the Partial Opioid Agonist class and Gabapentin belongs to the Anticonvulsant / Nerve Pain Agent class - two categories that can collide when co-prescribed. The mechanism described in FDA labeling is: Both drugs can slow down your brain and nervous system, which can lead to extreme sleepiness or slowed breathing. Severity tiers matter: major flags generally advise avoidance, moderate flags often require monitoring or dose adjustment, and minor flags may only call for awareness.

Context around a specific patient determines real-world impact. Buprenorphine (Pain) has 19 total documented interactions on file in this dataset, and Gabapentin has 19. Each additional medication compounds the interaction surface, which is why pharmacists run full-profile checks rather than evaluating one pair at a time. FDA-derived guidance for this pair is: Avoid taking these together unless specifically directed by your doctor. Timing of doses, renal and hepatic function, age, and other concurrent prescriptions all shape whether a labeled interaction matters clinically.

An interaction flag is not a verdict. A large share of labeled interactions are managed routinely in clinical practice, the fix may be as simple as spacing doses or adding a monitoring test. Others require the prescriber to choose a different medication entirely. This page surfaces FDA-sourced labeling and openFDA data for educational purposes only; it is not medical advice and cannot account for your full clinical picture. Never start, stop, or adjust either Buprenorphine (Pain) or Gabapentin based on a web page, speak with your prescriber or pharmacist before making any change.